Aubrey Capital Management’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-12,243
| Closed | -$346K | – | 66 |
|
|
2024
Q3 | $346K | Sell |
12,243
-13,216
| -52% | -$374K | 0.13% | 48 |
|
|
2024
Q2 | $536K | Sell |
25,459
-5,160
| -17% | -$109K | 0.21% | 44 |
|
|
2024
Q1 | $736K | Sell |
30,619
-2,472
| -7% | -$59.4K | 0.26% | 40 |
|
|
2023
Q4 | $926K | Buy |
+33,091
| New | +$926K | 0.39% | 41 |
|
|
2022
Q4 | – | Sell |
-15,600
| Closed | -$629K | – | 54 |
|
|
2022
Q3 | $629K | Buy |
15,600
+5,500
| +54% | +$222K | 0.54% | 26 |
|
|
2022
Q2 | $430K | Hold |
10,100
| – | – | 0.35% | 35 |
|
|
2022
Q1 | $394K | Buy |
+10,100
| New | +$394K | 0.23% | 47 |
|